Quarterly results

Search for previous results

Latest results

2017 First Quarter

Watch Simon Dingemans, CFO, discuss our first quarter results 2017.

Listen to the webcast View the press release

Actual Exchange Rates (AER)

  • +19%

    GSK Group sales

  • +17%

    Pharma sales growth

  • +31%

    Vaccines sales growth

  • +16%

    Consumer Healthcare sales growth

  • +31%

    Adjusted EPS

  • +72%

    New product sales

Constant Exchange Rates (CER)

  • +5%

    GSK Group sales

  • +4%

    Pharma sales growth

  • +16%

    Vaccines sales growth

  • +2%

    Consumer Healthcare sales growth

  • +9%

    Adjusted EPS

  • +52%

    New product sales

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
Back to top